Innocoll Pharmaceuticals Ltd. Sustainability Profile
Innocoll Pharmaceuticals Ltd., headquartered in Ireland (IE), is a prominent player in the biopharmaceutical industry, specialising in innovative drug delivery systems and advanced wound care solutions. Founded in 2003, the company has made significant strides in developing unique products that address unmet medical needs, particularly in the fields of orthopaedics and surgical care. Innocoll's core offerings include its proprietary collagen-based products, which stand out for their biocompatibility and effectiveness in promoting healing. With a strong focus on research and development, Innocoll has achieved notable milestones, including successful clinical trials and strategic partnerships that enhance its market position. As a leader in its sector, Innocoll Pharmaceuticals continues to drive advancements in patient care, solidifying its reputation as a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Innocoll Pharmaceuticals Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Innocoll Pharmaceuticals Ltd.'s score of 13 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Innocoll Pharmaceuticals Ltd.'s reported carbon emissions
Innocoll Pharmaceuticals Ltd., headquartered in Ireland (IE), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established any documented reduction targets or commitments to climate initiatives, which suggests a lack of formalised climate strategy at this time. It is important to note that Innocoll Pharmaceuticals Ltd. is a current subsidiary and may inherit climate-related data and commitments from its parent organisation. However, no specific details regarding such cascaded data or initiatives have been provided. As the pharmaceutical industry increasingly focuses on sustainability and carbon reduction, Innocoll Pharmaceuticals Ltd. may need to consider developing its own climate commitments to align with industry standards and expectations.
How Carbon Intensive is Innocoll Pharmaceuticals Ltd.'s Industry?
How Carbon Intensive is Innocoll Pharmaceuticals Ltd.'s Location?
Innocoll Pharmaceuticals Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Innocoll Pharmaceuticals Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.